Figure 3: Distribution of HTAs for selected medicines by geography and outcome
Number of HTA Decisions
Positive
Neutral
Negative
0
2
4
6
7
3
2
1
1
1
1
Japan
UK
Canada
Austria
Finland
France
Germany